Insulin use increases risk of asthma but metformin use reduces the risk in patients with diabetes in a Taiwanese population cohort

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: Recent reports have suggested that insulin promotes airway smooth muscle contraction and enhances airway hyperresponsiveness, which are cardinal features of asthma. In contrast, metformin can reduce both airway inflammatory and remodeling properties. However, these results are all from in vitro and animal studies. This study investigated whether diabetes and various antidiabetic agents associate with the risk of asthma. Methods: We used a retrospective population-based cohort study using Taiwan's National Health Insurance claim database from 2000 to 2010 and a Cox proportional hazards regression model to compare the incidence of asthma between patients with diabetes (n = 19,428) and a matched non-diabetic group (n = 38,856). We also used a case-control study nested from the above cohort including 1,982 incident cases of asthma and 1,982 age- and sex-matched controls. A time density sampling technique was used to assess the effects of various antidiabetic agents on the risk of asthma. Results: The incidence of asthma was significantly higher in the diabetic cohort than that in the non-diabetic cohort after adjustment for age, sex, and obesity, with a hazard ratio of 1.30 (95% confidence interval [CI]: 1.24–1.38). Insulin was found to increase the risk of asthma among diabetic patients (odds ratio [OR] 2.23; 95% CI: 1.52–3.58). In contrast, the use of metformin correlated with a decreased risk of asthma (OR 0.75; 95% CI: 0.60–0.95). Conclusions: Individuals with diabetes are at an increased risk of asthma. Insulin may further increase the risk of asthma, but the risk could possibly be reduced by using metformin.

Original languageEnglish
Pages (from-to)1019-1025
Number of pages7
JournalJournal of Asthma
Volume54
Issue number10
DOIs
Publication statusPublished - 2017 Nov 26

Fingerprint

Metformin
Asthma
Insulin
Population
Confidence Intervals
Hypoglycemic Agents
Odds Ratio
Airway Remodeling
Incidence
National Health Programs
Muscle Contraction
Taiwan
Proportional Hazards Models
Smooth Muscle
Case-Control Studies
Cohort Studies
Obesity
Databases

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

@article{b209cb3ec12540288496ed0ea5d42bda,
title = "Insulin use increases risk of asthma but metformin use reduces the risk in patients with diabetes in a Taiwanese population cohort",
abstract = "Objective: Recent reports have suggested that insulin promotes airway smooth muscle contraction and enhances airway hyperresponsiveness, which are cardinal features of asthma. In contrast, metformin can reduce both airway inflammatory and remodeling properties. However, these results are all from in vitro and animal studies. This study investigated whether diabetes and various antidiabetic agents associate with the risk of asthma. Methods: We used a retrospective population-based cohort study using Taiwan's National Health Insurance claim database from 2000 to 2010 and a Cox proportional hazards regression model to compare the incidence of asthma between patients with diabetes (n = 19,428) and a matched non-diabetic group (n = 38,856). We also used a case-control study nested from the above cohort including 1,982 incident cases of asthma and 1,982 age- and sex-matched controls. A time density sampling technique was used to assess the effects of various antidiabetic agents on the risk of asthma. Results: The incidence of asthma was significantly higher in the diabetic cohort than that in the non-diabetic cohort after adjustment for age, sex, and obesity, with a hazard ratio of 1.30 (95{\%} confidence interval [CI]: 1.24–1.38). Insulin was found to increase the risk of asthma among diabetic patients (odds ratio [OR] 2.23; 95{\%} CI: 1.52–3.58). In contrast, the use of metformin correlated with a decreased risk of asthma (OR 0.75; 95{\%} CI: 0.60–0.95). Conclusions: Individuals with diabetes are at an increased risk of asthma. Insulin may further increase the risk of asthma, but the risk could possibly be reduced by using metformin.",
author = "Chiung-Zuei Chen and Hsu, {Chih Hui} and Chung-Yi Li and Tzuen-Ren Hsiue",
year = "2017",
month = "11",
day = "26",
doi = "10.1080/02770903.2017.1283698",
language = "English",
volume = "54",
pages = "1019--1025",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Insulin use increases risk of asthma but metformin use reduces the risk in patients with diabetes in a Taiwanese population cohort

AU - Chen, Chiung-Zuei

AU - Hsu, Chih Hui

AU - Li, Chung-Yi

AU - Hsiue, Tzuen-Ren

PY - 2017/11/26

Y1 - 2017/11/26

N2 - Objective: Recent reports have suggested that insulin promotes airway smooth muscle contraction and enhances airway hyperresponsiveness, which are cardinal features of asthma. In contrast, metformin can reduce both airway inflammatory and remodeling properties. However, these results are all from in vitro and animal studies. This study investigated whether diabetes and various antidiabetic agents associate with the risk of asthma. Methods: We used a retrospective population-based cohort study using Taiwan's National Health Insurance claim database from 2000 to 2010 and a Cox proportional hazards regression model to compare the incidence of asthma between patients with diabetes (n = 19,428) and a matched non-diabetic group (n = 38,856). We also used a case-control study nested from the above cohort including 1,982 incident cases of asthma and 1,982 age- and sex-matched controls. A time density sampling technique was used to assess the effects of various antidiabetic agents on the risk of asthma. Results: The incidence of asthma was significantly higher in the diabetic cohort than that in the non-diabetic cohort after adjustment for age, sex, and obesity, with a hazard ratio of 1.30 (95% confidence interval [CI]: 1.24–1.38). Insulin was found to increase the risk of asthma among diabetic patients (odds ratio [OR] 2.23; 95% CI: 1.52–3.58). In contrast, the use of metformin correlated with a decreased risk of asthma (OR 0.75; 95% CI: 0.60–0.95). Conclusions: Individuals with diabetes are at an increased risk of asthma. Insulin may further increase the risk of asthma, but the risk could possibly be reduced by using metformin.

AB - Objective: Recent reports have suggested that insulin promotes airway smooth muscle contraction and enhances airway hyperresponsiveness, which are cardinal features of asthma. In contrast, metformin can reduce both airway inflammatory and remodeling properties. However, these results are all from in vitro and animal studies. This study investigated whether diabetes and various antidiabetic agents associate with the risk of asthma. Methods: We used a retrospective population-based cohort study using Taiwan's National Health Insurance claim database from 2000 to 2010 and a Cox proportional hazards regression model to compare the incidence of asthma between patients with diabetes (n = 19,428) and a matched non-diabetic group (n = 38,856). We also used a case-control study nested from the above cohort including 1,982 incident cases of asthma and 1,982 age- and sex-matched controls. A time density sampling technique was used to assess the effects of various antidiabetic agents on the risk of asthma. Results: The incidence of asthma was significantly higher in the diabetic cohort than that in the non-diabetic cohort after adjustment for age, sex, and obesity, with a hazard ratio of 1.30 (95% confidence interval [CI]: 1.24–1.38). Insulin was found to increase the risk of asthma among diabetic patients (odds ratio [OR] 2.23; 95% CI: 1.52–3.58). In contrast, the use of metformin correlated with a decreased risk of asthma (OR 0.75; 95% CI: 0.60–0.95). Conclusions: Individuals with diabetes are at an increased risk of asthma. Insulin may further increase the risk of asthma, but the risk could possibly be reduced by using metformin.

UR - http://www.scopus.com/inward/record.url?scp=85014492642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014492642&partnerID=8YFLogxK

U2 - 10.1080/02770903.2017.1283698

DO - 10.1080/02770903.2017.1283698

M3 - Article

C2 - 28135899

AN - SCOPUS:85014492642

VL - 54

SP - 1019

EP - 1025

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 10

ER -